Filter
464
Filtered Results: 464
Text search:
biomarkers
Featured
Recommendations
45
New Publications
98
Language
Document type
No document type
218
Studies & Reports
132
Guidelines
68
Manuals
18
Strategic & Response Plan
12
Fact sheets
8
Training Material
4
Resource Platforms
2
Situation Updates
1
Online Courses
1
Countries / Regions
India
50
Global
26
Africa
12
Kenya
10
Malawi
10
Russia
10
Western and Central Europe
9
Ghana
8
Nigeria
8
Germany
8
South Africa
8
Zambia
8
Nepal
7
Latin America and the Carribbean
6
Tanzania
6
Eastern Europe
6
Ethiopia
6
Ukraine
5
Sierra Leone
5
Zimbabwe
5
Asia
5
South–East Asia Region
5
Brazil
5
Lesotho
4
Rwanda
4
Uganda
4
Indonesia
4
Liberia
4
Myanmar / Burma
4
Philippines
3
Cambodia
3
Congo, Democratic Republic of
3
Bangladesh
3
Georgia
3
Burkina Faso
2
Eswatini/ Swaziland
2
Pakistan
2
Tajikistan
1
China
1
Syria
1
Albania
1
Senegal
1
Estonia
1
Afghanistan
1
Mozambique
1
USA
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Portugal
1
East and Southern Africa
1
Argentina
1
Sri Lanka
1
Namibia
1
Yemen
1
Romania
1
Angola
1
Authors & Publishers
Publication Years
Category
Countries
171
Clinical Guidelines
55
Public Health
30
Women & Child Health
14
Key Resources
10
Pharmacy & Technologies
6
Toolboxes
TB
48
Mental Health
37
HIV
36
NCDs
35
NTDs
31
COVID-19
25
AMR
17
Planetary Health
15
Rapid Response
8
Caregiver
7
Global Health Education
6
Refugee
3
Ebola & Marburg
3
Malaria
3
Specific Hazards
2
Pharmacy
2
Health Financing Toolbox
2
Natural Hazards
1
Social Ethics
1
The aim of this handbook is to provide network members and other laboratories involved in the diagnosis of tuberculosis, with an agreed list of key diagnostic methods and their protocols in various areas of TB diagnosis, ranging from microbiological diagnosis of active TB to the diagnosis of latent ...
Bisher hat die STIKO empfohlen, dass alle im Ausland mit einem nicht in der EU zugelassenen Impfstoff geimpften Personen eine erneute Impfserie mit einem in der EU zugelassenen Impfstoff erhalten sollen. Ziel der im Epidemiologischen Bulletin 13/2022 veröffentlichten aktualisierten COVID-19-Impfemp...
May 2021
This report presents the key findings of the NFHS-5 survey in Andhra Pradesh, followed by detailed tables and an appendix on sampling errors. The 2019-21 National Family Health Survey (NFHS-5), the fifth in the NFHS series, provides information on population, health, and nutrition for Indi...
It is estimated that more than 311 000 women die of cervical
cancer each year. Of these deaths, 91% occur in low- and
middle-income countries. Demographic changes and a lack of
action mean that the number of deaths per year is projected
to reach 460 000 by 2040.
WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention
recommended
2nd edition, July 2021. This WHO and HRP guideline is designed to help countries make faster progress, more equitably, on the screening and treatment of cervical cancer. It includes some important shifts in WHO’s recommended approaches to cervical screening, and includes a total of 23 recommendati...
Regional implementation framework for elimination of cervical cancer as a public health problem: 2021–2030
recommended
Cervical cancer continues to be a significant public health problem and a major cause of premature mortality among women, disproportionately affecting the socioeconomically disadvantaged population in low- and middle-income countries (LMICs). In the absence of implementing the known evidence-based, ...
Guidelines for the Prevention and Containment of Antimicrobial Resistance in South African Hospitals
These guidelines form part of efforts to institutionalise the prevention and containment of antimicrobial resistance (AMR) in health care facilities in South Africa, as outlined in the Antimicrobial Resistance Strategic Framework and Implementation Plan. The focus of these guidelines is on two inte...
April 2021
This report presents the key findings of the NFHS-5 survey in Assam, followed by detailed tables and an appendix on sampling errors. The 2019-21 National Family Health Survey (NFHS-5), the fifth in the NFHS series, provides information on population, health, and nutrition for India and e...
December 2022
This report presents the key findings of the NFHS-5 survey in Tamil Nadu, followed by detailed tables and an appendix on sampling errors. The 2019-21 National Family Health Survey (NFHS-5), the fifth in the NFHS series, provides information on population, health, and nutrition for Ind...
2nd edition. The purpose of the WHO human health risk assessment toolkit: chemical hazards is to provide its users with guidance to identify, acquire and use the information needed to assess chemical hazards, exposures and the corresponding health risks in their given health risk assessment contexts...
May 2021
This report presents the key findings of the NFHS-5 survey in Telangana, followed by detailed tables and an appendix on sampling errors. The 2019-21 National Family Health Survey (NFHS-5), the fifth in the NFHS series, provides information on population, health, and nutrition for India and...
March 2021
This report presents the key findings of the NFHS-5 survey in Goa, followed by detailed tables and an appendix on sampling errors. The 2019-21 National Family Health Survey (NFHS-5), the fifth in the NFHS series, provides information on population, health, and nutrition for India and eac...
March 2021
This report presents the key findings of the NFHS-5 survey in Maharashtra, followed by detailed tables and an appendix on sampling errors. The 2019-21 National Family Health Survey (NFHS-5), the fifth in the NFHS series, provides information on population, health, and nutrition for India...
This report presents the key findings of the NFHS-5 in West Bengal, followed by detailed tables and an appendix on sampling errors. At the time of finalization of this report, wealth quintiles for the country as a whole were not ready. Therefore, on finalization of the national report, the breakup o...
Trachoma is the leading infectious cause of blindness worldwide. In April 2023, it was a public health problem
in approximately 40 countries, with an estimated 116 million people at risk and 1.5 million people affected
by the late blinding stage of the disease (1). About 84% of those at risk of tr...
